NANOVIRICIDES, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
NANOVIRICIDES, INC. (NNVC) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 21.86% for the 3-month period ending 2014-09-30, per its 10-Q/A filed 2015-02-23.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2015-02-23
- NANOVIRICIDES, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2014-09-30 was 21.86%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month |
|---|---|
| 2014-09-30 | 21.86% 10-Q/A · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |